| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Mar 24, 2017 |
|||||||||
|
REX American Resources
REX
|
Q4 FY16 | $0.31 | $0.10 | $121.59M | $97.49M |
NYSE |
|||
|
QXO Inc
QXO
|
- | $0.11 | - | $8.24M | - |
NYSE |
|||
|
Crescent Capital BDC
CCAP
|
- | $0.72 | - | $5.02M | - |
NASDAQ |
|||
|
Boston Omaha
BOC
|
- | -$0.13 | - | $1.29M | - |
NYSE |
|||
|
Viridian Therapeutics
VRDN
|
- | -$7.23 | - | $756K | - |
NASDAQ |
|||
|
CKX Lands
CKX
|
- | $0.03 | - | $225.40K | - |
AMEX |
|||
|
Quoin Pharmaceuticals
QNRX
|
- | -$17.50 | -$50.00 | - | - |
NASDAQ |
|||
